Alessandro Bittoni
7PUBLICATIONS
30CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Oct 29, 2025
Real-World Evidence of Regorafenib Dose Escalation Versus Fixed Dosing in Refractory Metastatic Colorectal Cancer: Results from the ReTrITA Study.Carlo Signorelli, Michele Basso, Maria Alessandra Calegari
|Jun 26, 2025
Redefining the Use of Regorafenib and Trifluridine/Tipiracil Without Bevacizumab in Refractory Metastatic Colorectal Cancer: Findings from the ReTrITA Study.Carlo Signorelli, Maria Alessandra Calegari, Annunziato Anghelone
|Dec 27, 2024
Survival Outcomes with Regorafenib and/or Trifluridine/Tipiracil Sequencing to Rechallenge with Third-Line Regimens in Metastatic Colorectal Cancer: A Multicenter Retrospective Real-World Subgroup Comparison from the ReTrITA Study.Carlo Signorelli, Maria Alessandra Calegari, Annunziato Anghelone
|Oct 26, 2024
Multigene Panel Next-Generation Sequencing Techniques in the Management of Patients with Metastatic Colorectal Carcinoma: The Way Forward for Personalized Treatment? A Single-Center Experience.Laura Matteucci, Francesco Giulio Sullo, Chiara Gallio
|May 11, 2024
Advancing Personalized Medicine in the Treatment of Locally Advanced Rectal Cancer.Francesco Giulio Sullo, Alessandro Passardi, Chiara Gallio
|Dec 18, 2023
Inflammatory indices as prognostic markers in metastatic colorectal cancer patients treated with chemotherapy plus Bevacizumab.Alessandro Passardi, Irene Azzali, Alessandro Bittoni
Pageof 2
Frequent Collaborators
6 joint publications
Alessandro Passardi
3 joint publications
Giulia Arrivi
3 joint publications
Ina Valeria Zurlo
3 joint publications
Fiorenza Santamaria
3 joint publications
Chiara Gallio
3 joint publications
Carlo Signorelli
2 joint publications
Jessica Lucchetti
2 joint publications
Ilario Giovanni Rapposelli
2 joint publications
Annunziato Anghelone
2 joint publications
Maria Alessandra Calegari
